Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons.

Akkoç, Nurullah; Arteaga, Carlos H; Auteri, Simone E; Betts, Marissa; Fahrbach, Kyle; Kim, Mindy; Kiri, Sandeep; Neupane, Binod; Gaffney, Karl; Mease, Philip J

Akkoç, Nurullah; Arteaga, Carlos H; Auteri, Simone E; Betts, Marissa; Fahrbach, Kyle; Kim, Mindy; Kiri, Sandeep; Neupane, Binod; Gaffney, Karl; Mease, Philip J.

Afiliação

Akkoç N; Division of Rheumatology, Department of Medicine, Manisa Celal Bayar University School of Medicine, Mimar Sinan Blv. No: 173, 45030, Yunusemre/Manisa, Turkey. nurullah.akkoc@gmail.com.
Arteaga CH; UCB Pharma, Milan, Italy.
Auteri SE; UCB Pharma, Milan, Italy.
Betts M; Evidence Synthesis, Modeling & Communication, Evidera, Waltham, MA, USA.
Fahrbach K; Evidence Synthesis, Modeling & Communication, Evidera, Waltham, MA, USA.
Kim M; UCB Pharma, Raleigh, NC, USA.
Kiri S; UCB Pharma, Slough, England, UK.
Neupane B; Evidence Synthesis, Modeling & Communication, Evidera, Waltham, MA, USA.
Gaffney K; Rheumatology Department, Norfolk & Norwich University Hospital, Norwich, UK.
Mease PJ; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, USA.

Rheumatol Ther ; 10(2): 307-327, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36633815

Palavras-chave

Axial spondyloarthritis; Biologic DMARDs; Certolizumab pegol; Efficacy; Indirect treatment comparison

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Rheumatol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google